DRKS00017456已完成不适用
Retrospective Determination of BRAF V600E Mutation in Papillary Thyroid Cancer - BRAF-Study
Carl von Ossietzky Universität Oldenburg Fakultät VI - Medizin und Gesundheitswissenschaften0 个研究点目标入组 189 人开始时间: 2019年6月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 189
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •The resectates of all patients with papillary thyroid carcinoma who were taken from the Clinic for General and Visceral Surgery in the period 2007 to 2016 and for whom a declaration of consent is available are analyzed.
排除标准
- •All samples for which there is no declaration of informed consent from the patient will not be considered.
研究者
相似试验
招募中
不适用
Investigation of the BRAF mutation status in the pleural punctate in patients with malignant melanoma, colorectal or lung cancer, that show a BRAF mutation in the primary tumor and the comparison of the result with the conventional cytological / immunohistochemical and molecular cytology findings of the pleural punctateC43C34C18J90Malignant melanoma of skinMalignant neoplasm of bronchus and lungMalignant neoplasm of colonPleural effusion, not elsewhere classifiedDRKS00017491Onkologiezentrum Donauwörth15
Unknown
早期 1 期
BRAF V600E Mutations In Papillary Thyroid CarcinomaPapillary Thyroid CarcinomaNCT01417442Bezmialem Vakif University150
已完成
不适用
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)Multiple Myeloma, NeoplasmsNCT01804140Genentech, Inc.662
已完成
不适用
Detection of BRAF Mutation on FNAB From Papillary Thyroid CarcinomaPapillary Thyroid CarcinomaNCT02561533University of Aarhus53
已完成
不适用
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])MelanomaNCT03139513Hoffmann-La Roche200